fbpx

Month: July 2022

Inflação nos EUA atinge o maior valor em 41 anos

‘Recessão econômica no país é inevitável’, diz analista, para quem ‘coisas que realmente reduziriam os números não estão na agenda de Biden’

Divulgado hoje, o Índice de Preços ao Consumidor (CPI) nos EUA apontou que a inflação no país bateu 9,1% (ante 8,8% esperados pelo mercado), no acumulado de 12 meses encerrados em junho. Foi o maior nível para o período em 41 anos. Ante maio, a alta foi de 1,3% (mais que o 1,1% esperado pelo mercado).

Para Felipe Sichel, sócio e economista-chefe do Banco Modalmais, o índice teve leitura acima do esperado tanto no headline como na leitura subjacente (0,7% em comparação com a expectativa de 0,5%).

“Tanto o headline como a composição do índice são bastantes negativas para a trajetória da inflação nos EUA.”

Resultados preliminares do PIB americano entre os meses de abril a junho apontam para uma contração da atividade econômica. Enquanto isso, o Fed está considerando que taxas acentuadamente mais altas podem ser necessárias para conter a inflação.

Read the full text here

Bill Would Give US Production of Vital Electronics to China

The consequences of a bill in Congress will make you want to buy a new phone and laptop, provided that inflation leaves you with enough disposable income to do that.

While Americans are dealing with the effects of record-high gas prices, Democrats in Congress are suggesting the so-called PFAS Action Act, which would declare perfluoroalkyl and polyfluoroalkyl substances as hazardous chemicals. This legislation would open the gates for a ban on a large set of substances needed to produce everything from consumer electronics and vital medical equipment.

In an effort to preserve clean drinking water and protect consumer health, Democrats (and a handful of Republican co-sponsors of the bill) are throwing out the baby with the bathwater. PFAS, according to the CDC, englobes over 9,000 chemicals, which all have varying uses and severity.

Lawmakers in Washington are relying on cases of malpractice, when companies violated their duty to protect local communities by failing to ensure safe use, transport and disposal, to pull the rug out from this large set of substances.

Ultimately, why care? No citizen likes the idea of potentially toxic chemicals being in use at all, so why not just endorse this piece of legislation?

In fact, while within the set of 9,000 chemicals, some of them may very well need phasing out, others are essential to key American industries.

For instance, these chemicals are vital for the production of semiconductors, predominantly the use of coolant, and a ban would worsen the already existing chip shortage, which affects anything from mobile phones to electric cars. Computer chip shortages cost the U.S. economy $240 billion in 2021.

That said, waiting another six months for your electric vehicle or stomaching a significant price increase on your latest smartphone is just the tip of the iceberg. While regulators in the United States or Europe may decide to ban PFAS, manufacturers are unlikely to follow suit.

In fact, Beijing is famously less concerned than Western nations when it comes to chemical regulation, and would be more than happy to rake up the market shares made available by destructive environmental restrictions.

What message is Congress sending to American companies by considering this bill? Intel has announced it will spend $20 billion on a chip factory in Ohio, to stop the increasingly endemic lack of semiconductors. Presumably, Washington is thanking them by stripping the company of the tools to manufacture components and outsourcing the task to producers abroad.

When dealing with consumer goods, we should prefer that they are made with a transparent and reasonable regulatory framework that punishes wrongdoing to the full extent of the law, instead of relying on imports from nations that do not share our vision of safe manufacturing.

Originally published here

EPA Ignores the Pleas of Farmers on Crop Protection

The Environmental Protection Agency isn’t listening to farmers and its own scientific panel.

In a move that is causing American farmers significant distress, the Environmental Protection Agency (EPA) is effectively banning the use of the herbicide atrazine. 

The agency is lowering the so-called concentration equivalent level of concern (CE-LOC) to 3.4 ppb (parts per billion), making the substance unusable on farms across the country. The agency has thus undone an authorization dating back to 2016, going back to Obama-era rules, and reopening a political battle that implicates courts and regulators to do the strategic bidding for Washington.

Behind the definition of the concentration level of crop protection products and the associated court battles lies the fact that not even agriculture is spared by the partisan approach of lawmakers. Be it atrazine or the controversy surrounding glyphosate—environmental activists aim to phase out any herbicide, fungicide, or insecticide and push for an all-organic farming model. If the motivation for these bans were justified by a genuine concern for consumer health, they could be excused, but they appear to be associated with a manic opposition to modern farming, paired with a sinister belief in conspiracy theories.

Atrazine became popularly known through serial conspiracy peddler Alex Jones, who claimed that it was “turning the frogs gay,” while relying on one non-peer-reviewed and debunked study by a researcher named Tyrone Hayes from twenty years ago. The researcher had falsely claimed that the chemical created hermaphrodite frogs and altered their sexual orientation. Reviews by the EPA, German, and Australian regulators all found no evidence for the “gay frogs” premise. When researchers in Japan replicated Hayes’ experiment, they found no evidence either.

It wasn’t just fringe conspiracy theorists who used Hayes’ paper to claim that dark forces were attempting to kill masculinity by poisoning the drinking water—environmental groups also used the misleading conclusions. Beyond Pesticides, a group arguing for atrazine to be banned, writes: “EPA has long known about triazine’s threats to wildlife, including its ability to chemically castrate male frogs. However, the agency has consistently defended the chemical and sat by while independent researchers like Tyrone Hayes, PhD, who conducted seminal research on atrazine’s endocrine-disrupting properties, are pilloried by chemical industry propaganda.”

For consumers, the case for farmers being able to use adequate crop protection is better than just “this won’t harm you.” In fact, there are good reasons why atrazine, after glyphosate, remains the second most used herbicide in the United States. Consumers save $4.3 to almost $6.2 billionannually because the use of the product lowers prices for dairy products, eggs, and meat. 

Atrazine is used on twenty-four million acres of corn, sorghum, and sugarcane (for the first two, the United States is the world’s largest exporter). Without it, corn farmers would lose an estimated $3.1 to $4.6 billion per year, which would increase food insecurity and prices at a time when American consumers can afford it the least. Let’s not forget that compared to Europe, Americans spend a lot less on food: in 2020, Americans spent 5 percent of their disposable income on groceries, compared to 8.7 percent in Ireland (the lowest in the EU), 10.8 percent in Germany, 12 percent in Sweden, 17 percent in Hungary, and 25 percent in Romania.

A ban would also have environmental implications. The use of herbicides reduces the need for diesel-fueled tillage and avoids soil erosion. In practice, this means that less carbon dioxide is released into the atmosphere, and wildlife—such as birds—is less often disturbed by farmers passing over their fields. It also makes the farming system more efficient: all it takes to see that is to compare the American food model with the African, where pesticide availability is low and where farmers lose 40-100 percent of their crops. Herbicides essentially guarantee that we produce more with less and guarantee that we maintain affordable and available food.

The reasoning for the ban is based, just as with the example of Tyrone Hayes, on bad science. In fact, the Science Advisory Panel (SAP) of the EPA has alerted its own administrators to the fact that most of the studies it uses to argue for a ban “have weaknesses in their design” which “render interpreting their results and scoring them for “effects” or “no effect” difficult and subjective.” Why is the EPA not listening to its own scientists?

Farmers have also fired back at the EPA, calling its statements “untrue,” and saying that its new concentration level is “based on shaky scientific evidence derived through a process that has not been transparent.” They continue by arguing that atrazine is essential for carbon sequestration, essentially telling the EPA that its decision will lead to higher carbon dioxide emissions over time.

The EPA isn’t listening to farmers and its own scientific panel. Maybe it will reconsider once consumers feel the effect of a decision that will severely affect food prices.

Originally published here

The conflict between government agencies regarding PFAS

As discussed by the Star Tribune’s June 27 editorial (“Needed action on ‘forever chemicals'”), the Environmental Protection Agency is seeking to create clean drinking water thresholds on per- and polyfluoroalkyl substances (PFAS). Given the history of egregious cases of chemical dumping, like what was done by Dupont, popularized by the film “Dark Waters” with Mark Ruffalo, one can see why the EPA is taking such an approach to how PFAS are regulated in the United States.

Strangely enough though, the EPA’s approach to PFAS is at odds with another government body, the Food and Drug Administration.

The FDA, the regulatory body responsible for ensuring that pharmaceuticals and medical devices work and that their health benefits outweigh their known risks, has continuously approved both drugs and devices that contain PFAS. Most don’t know that the medical community is heavily reliant on PFAS products. Take, for example, medical implants like vascular grafts, stent grafts, surgical meshes, catheter tubes/wire and heart patches. It is estimated that 8% to 10% of Americans have implantable medical devices, many of which rely on PFAS and are approved by the FDA. In fact, the implantable medical-devices market, valued at $72.2 billion, is expected to grow significantly as the American population continues to get older.

Drugs containing PFAS and conditions with treatments that introduce the presence of PFAS include, but are not limited to, tachyarrhythmias (flecainide), antidepressants (fluoxetine), nonsteroidal anti-inflammatories (celecoxib), antibiotics (levofloxacin), rheumatoid arthritis therapeutics (leflunomide), cholesterol-lowering agents (atorvastin) and even COVID-19 antivirals such as Paxlovid.

For all of those drugs and devices, the notoriously overcautious FDA has clearly stated that whatever PFAS exposure exists with these products, they are safe to the point where the benefits far outweigh the risks. Simply put, the presence of PFAS for these drugs and devices passes a safety check and a cost-benefit analysis.

What we have here is two government agencies taking drastically different approaches to the issue of PFAS. On one hand, the FDA is doing a cost-benefit analysis and approving the use of PFAS across the medical sector, while the EPA is seeking to enact drinking water standards that are mutually exclusive to the FDA’s conclusions.

So how should regulators proceed given that the left hand and right hand of the federal government appear to be at odds with each other? One key step forward would be to individually assess each chemical within the PFAS umbrella, identify where hazards exist and calculate where Americans are actually at risk — with “risk” being the hazard present multiplied by the exposure levels.

After doing so, regulators should focus on ensuring proper production practices to avoid instances of dumping, and severely punish those companies caught being reckless in the production or disposal process. That is the approach that can keep Americans safe and their drinking water clean, without running the risk of having the regulatory system be so stringent that production ceases and American patients are left without the lifesaving drugs and devices they need.

Luckily, some voices of reason have emerged in Congress, like that of Rep. Larry Buschon of Indiana. As a heart surgeon by trade, he has rightfully pointed out that the heavy-handed approach would put lifesaving medical technologies at risk. Hopefully, more will listen, and the federal government, in coordination with state regulators, can both limit PFAS exposure where it is dangerous and allow for it to continue to be used where safe.

Originally published here

Can Joe Biden restore food trade talks with Europe?

For the EU, former President Donald Trump’s international policy was seen as a major regression for global trade policy. When former EU Commission President Jean-Claude Juncker signed the EU-Japan trade deal in 2018 — abolishing virtually all tariffs — Europe sold the move as being in significant contrast to the protectionism taken in the United States. That said, many EU member states prefer consumers only to buy European when it comes to food, even at the expense of major trade deals.

When Europe and the United States tripped up on the conclusion of the Transatlantic Trade and Investment Partnership (TTIP), it wasn’t because of the Obama administration at the time. Trade deals need to be approved by national parliaments, and the opposition of the Wallonian parliament (Southern Belgium) prevented the accord from being signed. Since then, more EU member countries have joined the protectionist club. France and Ireland have shown fierce opposition to trade between the EU and Mercosur, the South American trade bloc, over the competition that would ultimately arise for their national beef producers.

One year ago, U.S Secretary of Agriculture Thomas Vilsack explained to the European Parliament in a virtual appearance that the differences in how Europe and the United States treat crop protection and genetic engineering are an obstacle to the two blocs’ trading. The EU seeks to halve its pesticide use by 2030, with its soon-to-be-released Sustainable Use of Pesticides Directive (SUD), and it plans to continue to outlaw genetic engineering technology based on legislation going back to 2001. 

However, the ambitious agriculture reforms are now being questioned by its own member nations: Central and Eastern European countries have claimed that the goals are not feasible. French President Macron said in May that the strategy’s “objectives must be reviewed because under no circumstances can Europe afford to produce less,” and he added that a “deep food crisis” could emerge in the upcoming months.

Disagreements in Brussels have reached the European Commission, the executive arm of the European Union. Agriculture Commissioner Janusz Wojciechowski sings a different tune than Green Deal Commissioner Frans Timmermans. Wojciechowski aims to stall the release of the pesticide reduction targets, while Timmermans slams the opponents of the reforms in the light of the war in Ukraine as opportunistic.

Unlike in the American federal system, the European Commission will need the support of a large set of member states before proceeding, making the 50 percent cut more unlikely than previously believed. On top of that, England is currently mulling legislation (already introduced to the House of Commons) that would legalize gene-editing in the food sector, in what is one of the significant regulatory breaks since Brexit. Meanwhile, the European Union, which has reportedly been reviewing its statutes on the matter, comes under pressure as one of the few remaining developed nations that do not allow new technologies in food.

The existential question for European lawmakers is to what extent EU food rules are supposed to be exported elsewhere. The bloc prides itself on high food standards — yet, simultaneously catches itself contradicting its own food safety agencies and ends up embroiled in World Trade Organization (WTO) disputes over banning specific pesticides. According to Brussels, crop protection tools that are banned in the EU should also not be imported from elsewhere. Yet, instead of addressing regulatory concerns with trade partners, Europe makes up its mind unilaterally and informs trading nations via press releases. In times when Europe is more dependent than ever on friendly nations to provide anything from wheat to animal feed, it is hard to imagine that this approach will be long-lived.

For the Biden administration, this presents an opportunity to restore food trade talks with Europe. For too long American produce has been held back from the European market over an exaggerated mistrust of U.S food standards. As it dawns on Europe that it needs reliable partners to assure strategic autonomy, Washington should reach out and seize the opportunity. Perhaps we’re in need of a TTIP 2.0, or whatever we are choosing to name trade agreements these days.

Originally published here

The looming GP shortage is real – multiple prescriptions for the same problem

When something aches or you feel bad, the first place to go or call is the General Practitioner (GP). The NHS designed GPs as the entry point for most health-related issues. The aim of this system is threefold: (1) to get patients quick access to a medical doctor in his or her vicinity, (2) to have the GP assess the problem and either treat the patient on-site or refer the patient to a specialist, and (3) to optimise more expensive specialists’ time by only seeing patients that need to see a more advanced doctor.

So far so good. But a recent study by the Health Foundation suggests that by the end of this decade around a quarter of needed GPs will have left the labour market without being replaced. The NHS GP shortage should be taken seriously: If this unfolds the more specialised parts of the NHS might get overrun by patients and a domino effect could occur bringing down the entire care system in England.

But just recruiting another 10,000 GPs without changing the current NHS GP system might be hard to realise. So let’s look at the reasons for the looming shortage and incentives that could get us out of this situation.

A massively centralised system such as the NHS will over and over again encounter shortages of capacity, human resources, and drugs given its top-down funding structure. The predominant compensation driver for GPs is how many patients are enlisted with their practice – morbidity, quality of care, and efficiency of care play merely minor roles.

A much more decentralised outpatient care system that champions private clinics and private insurance at competing rates will be much better suited to quickly react to looming shortages by individually adjusting the pay of staff and the compensation for clinics. Patients might want to pay more for seeking care nearby or pay extra for same-day appointments.

One of the fundamental problems with highly centralised and politicised systems is that often patients have to figure out which practice can actually still accept patients. In a more agile system, the money needs to follow the patient and not the patient the money (the allocated resources in the system).

The NHS is not the envy of the world, no matter how often English politicians repeat that phrase. Even social democracies such as Germany rely much more on private elements in their primary health systems than the UK does – Switzerland and the Netherlands are two great examples. Patients should be much more in charge of deciding how and where their health contributions should be spent.

One idea to make it more attractive for medical students to choose a career as GP is creating healthcare vouchers that cover the basic NHS package for GPs (around 160 GBP/year and patient) but allow patients to redeem their vouchers at non-NHS practices and pay the difference out of pocket if these are more expensive or have the difference reimbursed by supplementary insurance. This would allow GPs to increase their profit and at the same time allow patients to transfer resources allocated within the NHS to a practice of their choice.

Opening up medical education to private universities in order to bring up the annual output of graduates from medical schools should also be one driver for more doctors available. Education, as healthcare, is too centralised and hence bottlenecks are inevitable.

At the same time, we need to make it easy for medical professionals from other countries (EU and non-EU countries) to migrate to the UK and quickly (maybe even immediately) work as GPs or specialists. I personally heard from medical doctors who emigrated to the UK what bureaucratic and certification ordeal they had to go through in order to practise in England.

Let’s keep in mind that the talent pipeline from admitting a student to a medical college to having a GP is pretty much a decade. A quick change of the approach to primary care in England is needed if this problem should be successfully tackled.

Originally published here

Harm Reduction Takes a U-Turn on Vaping

Public health officials and those with significant sway in setting health policy were joyous last month when the Food and Drug Administration denied the ability of Juul Labs to continue selling its vaping device.

Handed down as a Marketing Denial Order, the decision forces gas stations, retailers and vape shops to pull Juul devices off the shelves, depriving consumers of their ability to buy these products through legal means.

Though the company has won a temporary stay by the D.C. District Court of Appeals, the FDA’s recent “nicotine zero” mandate — including limits on nicotine in cigarettes and bans on menthol tobacco products — shows the administration won’t back down on its plans to reduce nicotine consumption.

But that would be a real missed opportunity for public health.

Rather than banning consumer products or setting rigorous — if not impossible — standards for getting vaping products to market, the FDA could follow the president’s rhetoric and endorse tobacco harm reduction as an alternative.

As a matter of public health, harm reduction is one of the key pillars of President Biden’s National Drug Control Strategy, as he revealed in this year’s State of the Union address. This includes education, support, clean needle exchanges and safe injection sites for those addicted to drugs like heroin and other prescriptions. If this path is virtuous for those addicted to opioids, why shouldn’t it be the same for those addicted to nicotine, as practiced elsewhere?

The United Kingdom not only recognizes the benefits of vaping devices but actively recommends them in their own materials and the National Health Service, their state health system, championing the 1.2 million British vapers who have now quit smoking. Health wards in New Zealand routinely offer vaping products to patients.

If the United Kingdom and New Zealand can cite various studies and health surveys demonstrating that vaping devices are 95 percent less harmful than smoking, why does this evidence fail in crossing the ocean to American regulators?

If the latest Gallup polls are believed, 6 percent of Americans are vapers, most of whom make less than $40,000 yearly. That is the equivalent of 20 million vapers who have chosen a less harmful product to quell their nicotine cravings.

Twice that number —nearly 40 million — are still smokers, according to the CDC. Pivoting to a harm reduction strategy could easily save millions of lives.

That includes recognizing the vape shop owners, passionate vaper community groups, and tobacco control professionals who have come to rely on an entire industry of vaping products as a more effective strategy in eliminating the harms of tobacco.

Those who applaud the administration’s actions on Juul point to the company’s past advertising to youth and the higher uptake of young people to vaping devices. These are troubling situations that deserve careful consideration, public scorn and action, especially considering the effects of nicotine on adolescent brains.

That said, rather than mitigating these harms to young people and addressing them properly, why are we so quick to abandon 40 million smokers from the opportunity to switch to a less harmful product to satisfy their addiction?

Most vapers enjoy products from a competitive marketplace of open tank systems, disposables and pod tanks far from the grip of any tobacco executive. This point is often overlooked in the public debate on vaping.

If the pandemic taught us anything about public perceptions of risk, it is that we must empower individuals to make decisions to improve their own situation rather than making it for them.

Thwarting adult consumers’ ability to choose a healthier option is denying the genuine health benefits that come with embracing harm reduction.

We have laws for a reason, and they should be enforced to keep vape devices away from the hands of youth. Education and strong parental supervision would do wonders in keeping a generation from addiction.

But completely abandoning the prospect of a smoke-free society would be a folly, and it’s time our public health officials admit it.

Originally published here

New EU pesticide targets could lead to unintended consequences

With the EU proposing new measures to cut the use of pesticides by 50% this could lead to a spike in illicit trade warns Maria Chaplia.

EU Health and Food Safety Commissioner Stella Kyriakides recently proposed a major Sustainable Use of Pesticides law (SUR), calling for the use of pesticides as the “last resort” measure. The bill aims to set new binding pesticides targets for member states to cut their use within the EU by 50%. 

Limiting the tools of European farmers at a time when global food systems are struggling to cope with the consequences of the Russian war against Ukraine, is inhumane to say the least. It will not be long before we see another spike in illicit trade of pesticides.

Banning or overregulating products that consumers, or farmers (in the case of pesticides) need and want to use, especially during this challenging time in world history, does more harm than good

Pesticides are some of the most regulated products both in the EU and globally. If illegal pesticide producers were a single company they would be the 4th largest in the world in terms of value. In 2018, the EU Intellectual Property Office stated that €1.3 billion is lost every year due to fake pesticides. This translates to €299 million and 500 jobs lost per year in Germany, €240 million and 500 jobs each year lost in France, and €185 million and 270 jobs lost annually in Italy. 

The COVID-19 pandemic has also exacerbated this  trend in agriculture too, among other areas, such as alcohol. The more regulated the product is, the higher chances are that criminal networks will exploit the regulation to their benefit. For European consumers, illicit trade means trading product safety for more access to restricted goods. As the demand for illicit products such as alcohol, pesticides, and tobacco, to name a few, shifts to the black market, it seems that access is more important than safety.

Over the period 2011- 2018, the sales of pesticides remained stable at around 360 million kilograms per year in the EU. In France, for example, despite the government’s ambition to drive down the use of pesticides, demand for pesticides have risen considerably in the past years. In Poland, the sale of pesticides in 2016 increased by 12.3% compared to 2011. What this shows is that overregulating pesticides only boosts illicit trade.

A quick look at the role of pesticides in farming explains why demand for them persists. Pesticides are instrumental in helping farmers prevent and/or manage pests such as weeds, insects, and plant pathogens. Substantial increases in yields recorded over the past 80 years can be mainly attributed to the use of pesticides. 

When it comes to the illicit trade in any product, not just pesticides, increasing the customs control and penalty for counterfeiting activities seems like a straightforward solution. Neither of these can fully fix the issue which, however, does not undermine their significance as a tool to tackle illicit trade. Very few illicit trade crimes are taken to courts. For example, in Slovenia, 27.1 tons of illegal pesticides have been detected and seized since 2003, and yet not a single court case was initiated. In Belgium and Italy, the situation is not any better. The justice system should take illicit trade more seriously.

Along with increasing the punishment for illicit trade, it is also necessary to re-evaluate the vices of prohibition as a policy. Banning or overregulating products that consumers, or farmers (in the case of pesticides) need and want to use, especially during this challenging time in world history, does more harm than good. The EU’s approach to pesticides should be less rushed and more forward-looking.

Originally published here

June 2022

Want to know what the Consumer Choice Center team has been up to for the past month? Let’s go through some of our best moments together


European Railway Station Index 2022 is out!

Want to know which European cities offer the best experience for passengers traveling by train? We’ve got you covered. We looked at Europe’s 50 largest railway stations and ranked them in terms of passenger experience and a mix of factors ranging from how crowded platforms are and accessibility to the number of destinations. This year’s leader is Zurich HB followed by Frankfurt Main hbf and Munchen hbf. Make sure to read the full paper for more information on this!
READ MORE

Crossover episode between ConsEUmer podcast and Consumer Choice Radio

We had the hosts of ConsEUmer podcast and Consumer Choice Radio join their forces and deliver an amazing episode discussing G7 – politicians becoming jokers, Macron making a case for American oil and also giving an advice how tip in North America – very useful one for Europeans traveling across the atlantic. This also happens to be 80th episode of ConsEUmer podcast, give it a listen! 
LISTEN HERE

FDA’s Menthol Melee hosted by Yael

In response to the FDA’s proposed rules to outlaw both menthol cigarettes and all flavors in cigars, we hosted our own session, called the Menthol Melee. Yael brought together community organizers, law enforcement, researchers, and policy experts who talked about why the FDA’s proposed bans on flavored cigars and menthol cigarettes will do more harm than good, emphasizing the impact these bans will have on minority communities, interactions between police and citizens, illicit markets and safety, public health, and more. If you haven’t already, make sure to watch the full video!
WATCH HERE

Instead of embracing harm reduction, Canada is taking a step in the wrong direction

Ottawa is not only targeting vape flavours but also scaling up taxation. Targeting vaping with flavour bans and high taxation will certainly discourage people from vaping but it will also encourage some former smokers to go back to cigarettes and keep some current smokers from switching to vaping. Vaping is an effective harm reduction tool and should be incorporated into any plans of achieving a smoke-free society, as has already been done in the United Kingdom.
READ HERE

War-induced food crisis in Europe could serve as a good example for the US

The European Union’s ambitious Farm to fork strategy, among others aiming to reduce farmland by 10 percent, and cut pesticide use in half, has been put on hold due to war-induced food crisis, with Macron making it clear that now is not a good time for such drastic changes. Lawmakers in the United States have, in the past, attempted to copy European Union food regulations, but hopefully, the current European crisis will serve as a good example of why this is not such good of an idea for a country that has already fallen behind China and India on the worldwide scale of food production.
READ MORE

Not in my backyard mentality in crypto policy is a no-go!

In this blogpost, Yael points out everything that is wrong with the bill awaiting its fate in the Senate, that would impose a two-year moratorium on crypto mining permits, and launch an expansive environmental review. In times of such high inflation and having people who are locked out of the traditional finance and banking sector, their choices will become even more limited.
READ HERE
Thank you for your attention, as you can see it’s been quite a productive month! We have a lot of projects in progress, so make sure to follow our social mediato be the first to know about them!

May 2022

We’re back bringing you the latest updates from the team CCC. Let’s recap what we have been up to this past month!

Removing patent protection will cost us decades of progress

Member states of the World Trade Organization are discussing a draft agreement on TRIPS flexibility to waive intellectual property protections. If adopted, the agreement would legalise compulsory licencing, a practice that allows the government to hand out the right to produce COVID-19 vaccines without the consent of a patent owner. While the mass production of vaccines is a noble goal, Maria warns us that scraping patent protection will create a dangerous precedent and will put all future innovations in jeopardy.
READ MORE

Bees are doing just fine!

In his latest op-ed, Bill reiterates that declines of both managed and wild bees occur naturally through weather changes and the decisions of beekeepers about how many bees they currently need. Radical conservationists have blamed pesticides for the decline of bee population, even though there has been a 35% increase of beehives since 2000. Bill calls for journalists to do a better job at fact-checking and not to spread misinformation in their chase of catchy click baits.  
READ MORE

PFAS ban or EV transition? The choice is up to Democrats

Democrats have put electric vehicles at the heart of their climate ambitions. But little do they know that their green agenda can not be realized without PFAS, so-called forever chemicals that they want to ban altogether. In this op-ed, Maria and Anna pointed out that these chemicals are an essential part of green energy applications and argue that the ban will simply shift production to countries like China, giving them the upper hand for the production of EV battery, solar panels, and semiconductors.
READ HERE

Canada can learn a thing or two from the US on how to tackle a housing crisis

Our North American Affairs manager David has previously stated that exclusionary zoning is the root cause of the housing crisis. Recently, President Joe Biden voiced the same opinion and the federal government will be seeking to tackle this specific cause in their attempt to alleviate the crisis. The U.S. offers plenty of examples of state and municipal legislators carrying out dramatic zoning reforms which lead to decreasing rental prices. It’s time the Canadian government took and example, abolished exclusionary zoning and started building more houses
READ HERE

Keep an eye on our social media not to miss our first Index of the year

European Railway Stations Index 2022 is coming! We looked at Europe’s 50 largest railway stations and ranked them in terms of passenger experience and according to a mix of factors ranging from how crowded platforms are and accessibility to the number of destinations. Last year Leipzig Hauptbahnhof ended up in well-deserved first place, followed by Wien Hauptbahnhof.  Let’s see which railway station ends up leading the list of this year’s best railway stations.
CHECK OUT LAST YEAR’S INDEX 

Help us fight the Consumer Choice Supervillains

If you’re just as tired of being told what you can or can not consume as we are, we might have a solution for you. We need your help fighting consumer choice supervillains, like mini Michael Bloomberg and Sleepy Joe Biden, watch the video below to find out more!
WATCH HERE
That’s a wrap for this month! Make sure to follow us on our social mediachannels to get all the updates we couldn’t fit in here! See you next month
Scroll to top
en_USEN